Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
+0.11 (0.48%)
After Hours: 23.40 +0.18 (0.78%)
Mar 23, 4:47PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.99 - 23.39
52 week 19.58 - 29.85
Open 23.08
Vol / Avg. 0.00/839,935.00
Mkt cap 3.74B
P/E 24.44
Div/yield 0.04/0.69
EPS 0.95
Shares 159.88M
Beta 0.91
Inst. own 68%
Feb 8, 2017
Q4 2016 Bruker Corp Earnings Release (Estimated)
Jan 9, 2017
Bruker Corp at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 14.69% 9.59%
Operating margin 16.35% 11.57%
EBITD margin - 15.97%
Return on average assets 15.37% 8.73%
Return on average equity 40.10% 21.75%
Employees 6,000 -
CDP Score - -


United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Anthony L. Mattacchione Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Age: 61
Bio & Compensation  - Reuters
Mark Robert Munch Ph.D. Executive Vice President ; President - Bruker Nano Surfaces Division and Bruker MAT Group
Age: 54
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 39
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 62
Bio & Compensation  - Reuters
Stephen W. Fesik Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Marc A. Kastner Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters
Richard D. Kniss Independent Director
Age: 75
Bio & Compensation  - Reuters